20030106
 Pfizer Agrees to Modify Zithromax Marketing   By By Scott Hensley, The Wall Street Journal,  Jan 7, 2003  The states alleged the company misrepresented the efficacy of Zithromax compared with other antibiotics because it can be used to treat ear infections with fewer doses over fewer days. Pfizer said in a statement that all of the advertising and promotional materials for Zithromax have been consistent with the medicine labeling approved by the Food and Drug Administration.   
